Sepantronium bromide (YM155) improves daratumumab-mediated cellular lysis of multiple myeloma cells by abrogation of bone marrow stromal cell-induced resistance.
View/ Open
Volume
101
Pagination
e339 - e342
DOI
10.3324/haematol.2015.139667
Journal
Haematologica